Assessment of Long-Term Diabetes Medication Use and Its Effects on Osteoporosis Risk in Diabetic Patients
DOI:
https://doi.org/10.17977/um067v6i12026p3Keywords:
ACCP, RF, Diabetic Mellitus, Osteoporosis, CK-MB, Vitamin D3Abstract
Background; Diabetes mellitus is a metabolic and systematic disorder that requires individualized therapy. The disease leads to various consequences, resulting in the destruction of tissues and organs. The aforementioned outcomes also include bone mineral disorders, caused by medications as well as diet therapy and physical activity.
Objective; Assessment of osteoporosis risk in diabetic patients with long-term diabetes medication use by detection some immunological and biochemical indicators.
Material and methods; The current study was conducted in Baqubah city/ Diyala province for the period; 1/10/2024 to 1/3/2025. 50 blood samples were collected from diabetic patients with osteoporosis who went to Baqubah Teaching Hospital as well as to the outpatient clinics. Also, 30 blood samples were collected from healthy people and considered as a control group. Serum levels of ACCP, CRP, CK-MP, Vitamin D3, calcium, and RF in all samples were quantified by AFIAS Machine. Present data were programmed by SPSS v. 20.0 and Graph pad prism v.6 statistical software.
Results; Present outcomes showed no significant differences (p>0.05) between males versus females and among age groups of patients. Also, current findings showed no significant differences between positivity of RF and study groups. Levels of CRP and CK-MP were high in patients compared to controls , while levels of Vitamin D3 and calcium were lowest in patients than control . In contrast, present study showed no differences (p>0.05) between levels of ACCP and study groups. Based on gender, present research showed no differences between positivity RF and groups (male vs. female vs. control). The levels of CRP and CK-MP scored highest mean level in males and lowest mean in females . On other hand, present findings showed the Vitamin D3 and calcium scored lowest level in males and highest mean in control . Finally, present study showed no differences (p>0.05) between levels of ACCP and groups (male vs. female vs. control).
Conclusions; The present study concluded the ACCP and RF indicator not play role in assessment osteoporosis in DM patients due to it isn’t levels affected by diseases, while CRP, calcium, CK-MB and vitamin D3 indicators have major role in assessment due to it is levels high affected by disease. Based on gender, present findings revealed there is variation in levels of CRP, calcium, CK-MB and vitamin D3 between males versus females due to hormonal and genetic disorders.
References
Abdalla, E., Gamar, A. M., Taha, Z. I., & Alfatih, M. (2024). Diabetic cheiroarthropathy in uncontrolled type 2 diabetes with positive anti-nuclear antibodies: A case report from Sudan. Annals of Medicine and Surgery, 86(6), 3631–3635.
Alam, M. S., Kaabi, Y. A., Hoque, M. M., Riyaz, F., Shah, M. H., Akhter, M. S., ... & Mjery, Y. (2024). Association between cardiac enzymes level in type 2 diabetes mellitus from Jazan Region, Saudi Arabia.
AlShomar, A., Al Abdulmonem, W., Ahmad, Q. S., Alharbi, M. S., Alkhiari, R., Hamad, E. M., & Rasheed, Z. (2023). Assessment of osteoporosis in patients with type 2 diabetes mellitus: A study from the central region of Saudi Arabia. Saudi Medical Journal, 44(7), 711.
Chen, M., Gerges, M., Raynor, W. Y., Park, P. S. U., Nguyen, E., Chan, D. H., & Gholamrezanezhad, A. (2024). State of the art imaging of osteoporosis. Seminars in Nuclear Medicine, 54(3), 415–426.
Cheng, X., Li, Y., Chui, X., Xin, Z., Ma, Z., Mei, P., ... & Jian, X. (2025). Energetic calcium phosphate nanominerals for osteoporosis treatment. Advanced Functional Materials, 35(8), 2415906.
De Martinis, M., Allegra, A., Sirufo, M. M., Tonacci, A., Pioggia, G., Raggiunti, M., ... & Gangemi, S. (2021). Vitamin D deficiency, osteoporosis and effect on autoimmune diseases and hematopoiesis: A review. International Journal of Molecular Sciences, 22(16), 8855.
D’Eufemia, P., Finocchiaro, R., Zambrano, A., Lodato, V., Celli, L., Finocchiaro, S., ... & Celli, M. (2017). Serum creatine kinase isoenzymes in children with osteogenesis imperfecta. Osteoporosis International, 28, 339–346.
Dong, Z., Li, M., Zhang, Y., Liu, H., & Cui, Y. (2023). Combined detection of vitamin D, CRP and TNF-α has high predictive value for osteoporosis in elderly men. American Journal of Translational Research, 15(8), 5536.
Elahi, R., Nazari, M., Mohammadi, V., Esmaeilzadeh, K., & Esmaeilzadeh, A. (2024). IL-17 in type II diabetes mellitus (T2DM) immunopathogenesis and complications: Molecular approaches. Molecular Immunology, 171, 66–76.
Fu, L. H., Yin, M., Chen, X., Yang, C., Lin, J., Wang, X., ... & Huang, P. (2025). Targeted management of diabetic osteoporosis by biocatalytic cascade reaction nanoplatform. Nano Letters.
Fujiwara, Y., Karol, A. B., Joshi, H., Reford, E., Izadmehr, S., Doroshow, D. B., & Galsky, M. D. (2024). C-reactive protein (CRP) as a prognostic biomarker in patients with urothelial carcinoma: A systematic review and meta-analysis. Critical Reviews in Oncology/Hematology, 197, 104352.
Hidayat, K., Fang, Q. L., Shi, B. M., & Qin, L. Q. (2021). Influence of glycemic control and hypoglycemia on the risk of fracture in patients with diabetes mellitus: A systematic review and meta-analysis of observational studies. Osteoporosis International, 32, 1693–1704.
Iyengar, K. P., Vaish, A., & Nune, A. (2022). Anti-cyclic citrullinated peptide antibody (ACPA) and rheumatoid arthritis: Clinical relevance. Journal of Clinical Orthopaedics and Trauma, 24, 101729.
Jiang, X. T., Ding, L., Huang, X., Lei, Y. P., Ke, H. J., Xiong, H. F., ... & Zhu, Y. (2023). Elevated CK-MB levels are associated with adverse clinical outcomes in acute pancreatitis: A propensity score-matched study. Frontiers in Medicine, 10, 1256804.
Karami, P., Gholamin, D., Fathi, F., Afsar, T., & Johari-Ahar, M. (2024). Anti-CCP biosensors in rheumatoid arthritis. Clinica Chimica Acta, 119767.
Latifjonovna, S. F. (2024). Diabetes mellitus and osteoporosis: A modern view of the problem and treatment options. Multidisciplinary Journal of Science and Technology, 4(4), 231–234.
Li, G., Prior, J. C., Leslie, W. D., Thabane, L., Papaioannou, A., Josse, R. G., ... & Adachi, J. D. (2019). Frailty and risk of fractures in patients with type 2 diabetes. Diabetes Care, 42(4), 507–513.
Lin, S., Li, J., Hu, X., Chen, S., Huang, H., Wu, Y., & Li, Z. (2024). Potential dietary calcium supplement: Calcium-chelating peptides and peptide-calcium complexes derived from blue food proteins. Trends in Food Science & Technology, 145, 104364.
Liu, Y., Tang, X. L., Ni, Y., Duan, L. Z., & Jing, F. J. (2024). Diagnostic value of the creatine kinase-MB/creatine kinase and neutrophil/lymphocyte ratios in acute myocardial infarction. Journal of Cardiothoracic Surgery, 19(1), 227.
Martiniakova, M., Biro, R., Kovacova, V., Babikova, M., Zemanova, N., Mondockova, V., & Omelka, R. (2024). Current knowledge of bone-derived factor osteocalcin: Its role in the management and treatment of diabetes mellitus, osteoporosis, osteopetrosis and inflammatory joint diseases. Journal of Molecular Medicine, 102(4), 435–452.
Nugroho, H., Kurniawan, R., & Purnami, C. T. (2024). Bone mineral density and osteoporosis related risk factors in type 2 diabetes mellitus. International Journal of Public Health Science, 13(2), 488–494.
Odum, E. P., & Young, E. E. (2018). Elevated cardiac troponin I, creatine kinase and myoglobin and their relationship with cardiovascular risk factors in patients with type 2 diabetes. Diabetes & Metabolic Syndrome, 12(2), 141–145.
Oka, S., Higuchi, T., Furukawa, H., Shimada, K., Okamoto, A., Hashimoto, A., ... & Tohma, S. (2022). Serum rheumatoid factor IgA, anti-citrullinated peptide antibodies with secretory components, and anti-carbamylated protein antibodies associate with interstitial lung disease in rheumatoid arthritis. BMC Musculoskeletal Disorders, 23, 1–8.
Pittas, A. G., Dawson-Hughes, B., Sheehan, P., Ware, J. H., Knowler, W. C., Aroda, V. R., ... & Staten, M. (2019). Vitamin D supplementation and prevention of type 2 diabetes. New England Journal of Medicine, 381(6), 520–530.
Salari, N., Ghasemi, H., Mohammadi, L., Behzadi, M. H., Rabieenia, E., Shohaimi, S., & Mohammadi, M. (2021). The global prevalence of osteoporosis in the world: A comprehensive systematic review and meta-analysis. Journal of Orthopaedic Surgery and Research, 16, 1–20.
Sim, G., Kim, Y., Lee, S. M., Hahn, J., & Kim, J. (2024). Role of vitamin D in prevention of type 2 diabetes mellitus: A systematic review and meta-analysis. Experimental and Therapeutic Medicine, 28(6), 451.
Steiner, G., & Toes, R. E. (2024). Autoantibodies in rheumatoid arthritis—Rheumatoid factor, anticitrullinated protein antibodies and beyond. Current Opinion in Rheumatology, 36(3), 217–224.
Tian, Z., McLaughlin, J., Verma, A., Chinoy, H., & Heald, A. H. (2021). The relationship between rheumatoid arthritis and diabetes mellitus: A systematic review and meta-analysis. Cardiovascular Endocrinology & Metabolism, 10(2), 125–131.
Tiwari, D., Khatoon, F., Manger, P. T., & Awasthi, R. (2024). A case-control study evaluating the predictive role of creatine kinase and lactate dehydrogenase in type 2 diabetes mellitus.
Tong, K. I., Hopstock, L. A., & Cook, S. (2023). Association of C-reactive protein with future development of diabetes: A population-based 7-year cohort study among Norwegian adults aged 30 and older in the Tromsø Study 2007–2016. BMJ Open, 13(9), e070284.
Wallace, H. J., Holmes, L., Ennis, C. N., Cardwell, C. R., Woodside, J. V., Young, I. S., ... & McKinley, M. C. (2019). Effect of vitamin D3 supplementation on insulin resistance and β-cell function in prediabetes: A double-blind, randomized, placebo-controlled trial. American Journal of Clinical Nutrition, 110(5), 1138–1147.
Wikarek, A., Grabarczyk, M., Klimek, K., Janoska-Gawrońska, A., Suchodolska, M., & Holecki, M. (2024). Effect of drugs used in pharmacotherapy of type 2 diabetes on bone density and risk of bone fractures. Medicina, 60(3), 393.
Yang, J., Park, Y., Lee, J. J., Kwok, S. K., Ju, J. H., Kim, W. U., & Park, S. H. (2025). Impact of glucocorticoids on denosumab efficacy in rheumatoid arthritis patients. Therapeutic Advances in Musculoskeletal Disease, 17, 1759720X251314712.
Zawada, A., Ratajczak, A. E., Rychter, A. M., Szymczak-Tomczak, A., Dobrowolska, A., & Krela-Kaźmierczak, I. (2022). Treatment of diabetes and osteoporosis—A reciprocal risk? Biomedicines, 10(9), 2191.
Zhang, C. (2025). Serum levels of IL-8, IL-10, TNF-α, cTnI, CK-MB in rheumatic heart disease patients treated with dexmedetomidine. Journal of Medical Biochemistry.
Zhang, E., Miramini, S., & Zhang, L. (2024). The impact of osteoporosis and diabetes on fracture healing under different loading conditions. Computer Methods and Programs in Biomedicine, 244, 107952.
Zhou, H. H., Tang, Y. L., Xu, T. H., & Cheng, B. (2024). C-reactive protein: Structure, function, regulation, and role in clinical diseases. Frontiers in Immunology, 15, 1425168.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Muayad AL-dulaimi, Saad M. Saeed
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
1.png)
4.png)
